376 related articles for article (PubMed ID: 20920219)
1. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.
Ellison-Zelski SJ; Alarid ET
Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219
[TBL] [Abstract][Full Text] [Related]
2. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer.
Li W; Zhang Z; Liu X; Cheng X; Zhang Y; Han X; Zhang Y; Liu S; Yang J; Xu B; He L; Sun L; Liang J; Shang Y
J Clin Invest; 2017 Sep; 127(9):3421-3440. PubMed ID: 28805661
[TBL] [Abstract][Full Text] [Related]
3. Repression of ESR1 through actions of estrogen receptor alpha and Sin3A at the proximal promoter.
Ellison-Zelski SJ; Solodin NM; Alarid ET
Mol Cell Biol; 2009 Sep; 29(18):4949-58. PubMed ID: 19620290
[TBL] [Abstract][Full Text] [Related]
4. A novel somatic mutation of SIN3A detected in breast cancer by whole-exome sequencing enhances cell proliferation through ERα expression.
Watanabe K; Yamamoto S; Sakaguti S; Isayama K; Oka M; Nagano H; Mizukami Y
Sci Rep; 2018 Oct; 8(1):16000. PubMed ID: 30375428
[TBL] [Abstract][Full Text] [Related]
5. The Sin3A/MAD1 Complex, through Its PAH2 Domain, Acts as a Second Repressor of Retinoic Acid Receptor Beta Expression in Breast Cancer Cells.
Dahiya NR; Leibovitch BA; Kadamb R; Bansal N; Waxman S
Cells; 2022 Mar; 11(7):. PubMed ID: 35406744
[TBL] [Abstract][Full Text] [Related]
6. Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth.
Tolhurst RS; Thomas RS; Kyle FJ; Patel H; Periyasamy M; Photiou A; Thiruchelvam PT; Lai CF; Al-Sabbagh M; Fisher RA; Barry S; Crnogorac-Jurcevic T; Martin LA; Dowsett M; Charles Coombes R; Kamalati T; Ali S; Buluwela L
Breast Cancer Res Treat; 2011 Jul; 128(2):357-68. PubMed ID: 20730598
[TBL] [Abstract][Full Text] [Related]
7. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
Peterson TJ; Karmakar S; Pace MC; Gao T; Smith CL
Mol Cell Biol; 2007 Sep; 27(17):5933-48. PubMed ID: 17591692
[TBL] [Abstract][Full Text] [Related]
8. Interference with Sin3 function induces epigenetic reprogramming and differentiation in breast cancer cells.
Farias EF; Petrie K; Leibovitch B; Murtagh J; Chornet MB; Schenk T; Zelent A; Waxman S
Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11811-6. PubMed ID: 20547842
[TBL] [Abstract][Full Text] [Related]
9. Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.
Singh RR; Barnes CJ; Talukder AH; Fuqua SA; Kumar R
Cancer Res; 2005 Nov; 65(22):10594-601. PubMed ID: 16288053
[TBL] [Abstract][Full Text] [Related]
10. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.
Karmakar S; Foster EA; Smith CL
Endocrinology; 2009 Apr; 150(4):1588-96. PubMed ID: 19095746
[TBL] [Abstract][Full Text] [Related]
11. Estrogen Receptor-β Modulation of the ERα-p53 Loop Regulating Gene Expression, Proliferation, and Apoptosis in Breast Cancer.
Lu W; Katzenellenbogen BS
Horm Cancer; 2017 Aug; 8(4):230-242. PubMed ID: 28577282
[TBL] [Abstract][Full Text] [Related]
12. Regulation of estrogen-dependent transcription by the LIM cofactors CLIM and RLIM in breast cancer.
Johnsen SA; Güngör C; Prenzel T; Riethdorf S; Riethdorf L; Taniguchi-Ishigaki N; Rau T; Tursun B; Furlow JD; Sauter G; Scheffner M; Pantel K; Gannon F; Bach I
Cancer Res; 2009 Jan; 69(1):128-36. PubMed ID: 19117995
[TBL] [Abstract][Full Text] [Related]
13. Differential regulation of estrogen receptor α expression in breast cancer cells by metastasis-associated protein 1.
Kang HJ; Lee MH; Kang HL; Kim SH; Ahn JR; Na H; Na TY; Kim YN; Seong JK; Lee MO
Cancer Res; 2014 Mar; 74(5):1484-94. PubMed ID: 24413532
[TBL] [Abstract][Full Text] [Related]
14. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
15. Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
Padua MB; Bhat-Nakshatri P; Anjanappa M; Prasad MS; Hao Y; Rao X; Liu S; Wan J; Liu Y; McElyea K; Jacobsen M; Sandusky G; Althouse S; Perkins S; Nakshatri H
Breast Cancer Res; 2018 May; 20(1):35. PubMed ID: 29720215
[TBL] [Abstract][Full Text] [Related]
16. Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1.
Xu Z; Yang Y; Li B; Li Y; Xia K; Yang Y; Li X; Wang M; Li S; Wu H
Cell Death Dis; 2018 May; 9(5):559. PubMed ID: 29752474
[TBL] [Abstract][Full Text] [Related]
17. TWIST represses estrogen receptor-alpha expression by recruiting the NuRD protein complex in breast cancer cells.
Fu J; Zhang L; He T; Xiao X; Liu X; Wang L; Yang L; Yang M; Zhang T; Chen R; Xu J
Int J Biol Sci; 2012; 8(4):522-32. PubMed ID: 22457607
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol, through NF-Y/p53/Sin3/HDAC1 complex phosphorylation, inhibits estrogen receptor alpha gene expression via p38MAPK/CK2 signaling in human breast cancer cells.
De Amicis F; Giordano F; Vivacqua A; Pellegrino M; Panno ML; Tramontano D; Fuqua SA; Andò S
FASEB J; 2011 Oct; 25(10):3695-707. PubMed ID: 21737614
[TBL] [Abstract][Full Text] [Related]
19. SnoN oncoprotein enhances estrogen receptor-α transcriptional activity.
Band AM; Laiho M
Cell Signal; 2012 Apr; 24(4):922-30. PubMed ID: 22227247
[TBL] [Abstract][Full Text] [Related]
20. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.
Gustafsson N; Zhao C; Gustafsson JA; Dahlman-Wright K
Cancer Res; 2010 Feb; 70(3):1265-74. PubMed ID: 20103625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
